AZD-9291

Grade: Pharmaceutical Grade

Factory Location: Shandong province

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

Monthly Production Capacity: 5kg

Packaging Information: 25kg/drum

Delivery Lead Time: 7DAYS

Sample Provided: yes

Payment Terms: TT

AZD-9291

CAS NO: 1421373-65-0

MF: C28H33N7O2

MW: 499.61

Orally bioavailable mutant-selective EGFR inhibitor that has been tested in Phase III clinical trials for treatment of Non-Small Cell Lung Cancer